Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014624

Director sold 12,452 shares at $10.24 ($127,477)

  • Director acquired 21,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kauffman Michael Director 2022-02-28 Grant or award +21,000 719,983 D: show line 1 in the form
Kauffman Michael Director 2022-02-28 Sale −6,226 $10.24 $63,739 713,757 D: show line 2 in the form
Kauffman Michael Director 2022-02-28 Sale −6,226 $10.24 $63,739 898,131 I: show line 3 in the form
Open-market sales · 12,452 sh · avg $10.24 · $127,477

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kauffman Michael Director 2022-02-28 Grant or award · Stock Option (right to buy) +27,000 27,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…